MEKTOVI Trademark

Trademark Overview


On Friday, June 6, 2014, a trademark application was filed for MEKTOVI with the United States Patent and Trademark Office. The USPTO has given the MEKTOVI trademark a serial number of 86302337. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 7, 2024. This trademark is owned by Novartis AG. The MEKTOVI trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharma...
mektovi

General Information


Serial Number86302337
Word MarkMEKTOVI
Filing DateFriday, June 6, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 7, 2024
Registration Number5346558
Registration DateTuesday, November 28, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2014

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 7, 2024
Primary Code005
First Use Anywhere DateThursday, September 21, 2017
First Use In Commerce DateThursday, September 21, 2017

Trademark Owner History


Party NameARRAY BIOPHARMA INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Party NameARRAY BIOPHARMA INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBOULDER, CO 80301

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Wednesday, July 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 10, 2014NEW APPLICATION ENTERED
Wednesday, June 18, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 10, 2014ASSIGNED TO EXAMINER
Friday, July 11, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 21, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 19, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 19, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 8, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, April 8, 2015SOU EXTENSION 1 FILED
Wednesday, April 8, 2015SOU EXTENSION 1 GRANTED
Friday, April 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 12, 2015SOU TEAS EXTENSION RECEIVED
Monday, October 12, 2015SOU EXTENSION 2 FILED
Wednesday, October 21, 2015SOU EXTENSION 2 GRANTED
Wednesday, September 21, 2016SOU TEAS EXTENSION RECEIVED
Thursday, October 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 27, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 10, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 10, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 11, 2016SOU TEAS EXTENSION RECEIVED
Friday, March 11, 2016SOU EXTENSION 3 FILED
Monday, March 14, 2016SOU EXTENSION 3 GRANTED
Tuesday, March 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2017SOU EXTENSION 5 FILED
Thursday, September 28, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, September 28, 2017USE AMENDMENT FILED
Tuesday, October 3, 2017STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 21, 2016SOU EXTENSION 4 FILED
Monday, September 26, 2016SOU EXTENSION 4 GRANTED
Tuesday, September 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, March 28, 2017SOU EXTENSION 5 GRANTED
Wednesday, March 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 26, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 28, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, October 25, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 4, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 4, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 4, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 28, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 7, 2024CANCELLED SEC. 8 (6-YR)